Product Description: Danburstotug (IMC-001) is an IgG1-lambda anti-CD274 (PDL1, B7 homologue 1, B7H1) human monoclonal antibody. Danburstotug also is immunostimulant and antineoplastic[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022.
CAS Number: 2307144-65-4
Molecular Weight: N/A
Research Area: Cancer; Inflammation/Immunology
Solubility: H2O
Target: PD-1/PD-L1